168 related articles for article (PubMed ID: 23284979)
1. An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.
Nava S; Dossena M; Pogliani S; Pellegatta S; Antozzi C; Baggi F; Gellera C; Pollo B; Parati EA; Finocchiaro G; Frigerio S
PLoS One; 2012; 7(12):e52301. PubMed ID: 23284979
[TBL] [Abstract][Full Text] [Related]
2. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
3. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.
Eyrich M; Schreiber SC; Rachor J; Krauss J; Pauwels F; Hain J; Wölfl M; Lutz MB; de Vleeschouwer S; Schlegel PG; Van Gool SW
Cytotherapy; 2014 Jul; 16(7):946-64. PubMed ID: 24831836
[TBL] [Abstract][Full Text] [Related]
5. Clinical-scale generation of dendritic cells in a closed system.
Sorg RV; Ozcan Z; Brefort T; Fischer J; Ackermann R; Müller M; Wernet P
J Immunother; 2003; 26(4):374-83. PubMed ID: 12843800
[TBL] [Abstract][Full Text] [Related]
6. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Curti A; Isidori A; Ferri E; Terragna C; Neyroz P; Cellini C; Ratta M; Baccarani M; Lemoli RM
Leuk Lymphoma; 2004 Jul; 45(7):1419-28. PubMed ID: 15359643
[TBL] [Abstract][Full Text] [Related]
7. A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.
Jarnjak-Jankovic S; Hammerstad H; Saebøe-Larssen S; Kvalheim G; Gaudernack G
BMC Cancer; 2007 Jul; 7():119. PubMed ID: 17608923
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.
Tešić N; Pekle Simonič I; Roškar K; Rožman P; Švajger U
Immunol Invest; 2020 Apr; 49(3):215-231. PubMed ID: 31170833
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
Meyer-Wentrup F; Burdach S
J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
[TBL] [Abstract][Full Text] [Related]
10. Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors.
Kvistborg P; Bechmann CM; Pedersen AW; Toh HC; Claesson MH; Zocca MB
Vaccine; 2009 Dec; 28(2):542-7. PubMed ID: 19837091
[TBL] [Abstract][Full Text] [Related]
11. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
[TBL] [Abstract][Full Text] [Related]
12. Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine.
Boudousquié C; Boand V; Lingre E; Dutoit L; Balint K; Danilo M; Harari A; Gannon PO; Kandalaft LE
Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31947581
[TBL] [Abstract][Full Text] [Related]
13. Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy.
Erdmann M; Uslu U; Wiesinger M; Brüning M; Altmann T; Strasser E; Schuler G; Schuler-Thurner B
J Immunol Methods; 2018 Dec; 463():89-96. PubMed ID: 30266448
[TBL] [Abstract][Full Text] [Related]
14. PGE
Nava S; Lisini D; Frigerio S; Pogliani S; Pellegatta S; Gatti L; Finocchiaro G; Bersano A; Parati EA
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131407
[TBL] [Abstract][Full Text] [Related]
15. Isolation and generation of clinical-grade dendritic cells using the CliniMACS system.
Campbell JD; Piechaczek C; Winkels G; Schwamborn E; Micheli D; Hennemann S; Schmitz J
Methods Mol Med; 2005; 109():55-70. PubMed ID: 15585913
[TBL] [Abstract][Full Text] [Related]
16. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
[TBL] [Abstract][Full Text] [Related]
17. Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production.
Adamson L; Palma M; Choudhury A; Eriksson I; Näsman-Glaser B; Hansson M; Hansson L; Kokhaei P; Osterborg A; Mellstedt H
Scand J Immunol; 2009 Jun; 69(6):529-36. PubMed ID: 19439014
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
Ponsaerts P; Van den Bosch G; Cools N; Van Driessche A; Nijs G; Lenjou M; Lardon F; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunol; 2002 Aug; 169(4):1669-75. PubMed ID: 12165485
[TBL] [Abstract][Full Text] [Related]
19. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
20. Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients.
Toungouz M; Quinet C; Thille E; Fourez S; Pradier O; Delville JP; Velu T; Lambermont M
Cytotherapy; 1999; 1(6):447-53. PubMed ID: 20426545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
